South Dakota 2025 Regular Session

South Dakota House Bill HB1016

Introduced
1/14/25  
Refer
1/14/25  
Report Pass
2/21/25  
Engrossed
2/25/25  
Refer
2/26/25  
Report Pass
3/3/25  
Enrolled
3/4/25  

Caption

Revise provisions related to pharmacy and to increase fees.

Impact

The bill is expected to have a significant impact on the operational framework of pharmacies in South Dakota. By enhancing the provisions related to remote pharmaceutical services, it seeks to improve accessibility for patients, particularly in areas lacking physical pharmacy locations. The revision includes increased licensing fees, which may affect the financial burden on new and existing pharmacy businesses. These measures are aimed at ensuring that pharmacies meet rigorous standards in terms of professional conduct and community service.

Summary

House Bill 1016 focuses on revising the existing provisions regarding pharmacy operations within South Dakota and aims to increase certain fees associated with pharmacy licensing and renewals. A notable feature of this bill is the regulation of telepharmacy, which expands the ability of pharmacies to provide services remotely, broadening access to licensed pharmacy care, especially in rural areas. Additionally, it stipulates requirements for the operation and maintenance of pharmacies to ensure compliance with health and safety standards.

Sentiment

General sentiment surrounding HB1016 appears to be cautiously optimistic. Supporters of the bill highlight the potential benefits of improved access to pharmacy services and the advancement of telepharmacy. However, there are concerns from some stakeholders regarding the increased fees which may pose challenges for smaller pharmacy operations. The balance between ensuring adequate services and managing operational costs remains a focal point of discussion.

Contention

Debate over HB1016 has brought several points of contention to light, particularly regarding the feasibility of increased fees and the implications for smaller pharmacies. While proponents argue that the updates are necessary for modernizing pharmacy practice and enhancing service delivery, opponents worry that the financial pressure could hinder small pharmacies, especially in underserved communities, leading to reduced service options in those areas.

Companion Bills

No companion bills found.

Similar Bills

VA HB1905

Compounding drugs; exceptions for distribution within hospital or health system.

VA SB1366

Compounding drugs; exceptions for distribution within hospital or health system.

MS SB2677

Pharmacy Benefit Prompt Pay Act; define requirements for pharmacy benefit managers and pharmacy services administrative organizations.

MD HB321

Pharmacy Benefits Managers – Definition of Purchaser and Alteration of Application of Law

MD SB303

Pharmacy Benefits Managers - Definition of Purchaser and Alteration of Application of Law

MS SB2675

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.

MS HB252

Pharmacists; authorize to test for and administer treatment for minor, nonchronic health conditions.

MS HB1413

Pharmacy Benefit Manager Transparency Act; create.